|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
17
|
|
pubmed:dateCreated |
1996-10-4
|
|
pubmed:abstractText |
The presence of metastatic tumor cells in the axillary lymph nodes is an important factor when deciding whether or not to treat breast cancer patients with adjuvant therapy. Positron emission tomography (PET) imaging with the radiolabeled glucose analogue 2-(fluorine-18)-fluoro-2-deoxy-D-glucose (F-18 FDG) has been used to visualize primary breast tumors as well as bone and soft-tissue metastases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0027-8874
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
4
|
|
pubmed:volume |
88
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1204-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8780629-Adult,
pubmed-meshheading:8780629-Aged,
pubmed-meshheading:8780629-Axilla,
pubmed-meshheading:8780629-Breast Neoplasms,
pubmed-meshheading:8780629-Deoxyglucose,
pubmed-meshheading:8780629-Female,
pubmed-meshheading:8780629-Fluorine Radioisotopes,
pubmed-meshheading:8780629-Fluorodeoxyglucose F18,
pubmed-meshheading:8780629-Humans,
pubmed-meshheading:8780629-Lymphatic Metastasis,
pubmed-meshheading:8780629-Middle Aged,
pubmed-meshheading:8780629-Predictive Value of Tests,
pubmed-meshheading:8780629-Sensitivity and Specificity,
pubmed-meshheading:8780629-Tomography, Emission-Computed
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
|
|
pubmed:affiliation |
Department of Nuclear Medicine, Technische Universität München, Federal Republic of Germany.
|
|
pubmed:publicationType |
Journal Article
|
